Faget Comments on New FDA Guidance

26 September 2019 Mobi Health News News

Special Counsel Kyle Faget  was quoted in a Mobi Health News article, “FDA releases revised draft guidance on CDS software, final guidelines on ‘device’ definitions for software such as wellness apps,” about new guidance designed to bring the agency’s efforts into compliance with provisions of the 21st Century Cures Act.

Faget said regulatory uncertainty stifles innovation either by discouraging innovators from entering a field where the regulatory uncertainty creates an unnecessary barrier to entry or by delaying commercialization as innovators seek clarification regarding the regulatory status of their software. “Now that these guidances are available and in final form, digital health developers will have to get to work operationalizing the principles articulated in the guidances,” she said.

Related Services

Insights

Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
$4.24M Now the Average Cost Per Data Breach!
30 July 2021
Internet, IT & e-Discovery Blog
Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
Foley Podcast to Live Panel Discussion
29 July 2021
Foley Career Perspectives
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream